Stonnington Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $697K | Buy |
9,323
+500
| +6% | +$37.4K | 0.18% | 120 |
|
|
2022
Q4 | $632K | Sell |
8,823
-500
| -5% | -$35.8K | 0.17% | 115 |
|
|
2022
Q3 | $508K | Sell |
9,323
-6,800
| -42% | -$371K | 0.14% | 128 |
|
|
2022
Q2 | $1.08M | Buy |
16,123
+2,200
| +16% | +$147K | 0.29% | 74 |
|
|
2022
Q1 | $983K | Buy |
13,923
+4,000
| +40% | +$282K | 0.24% | 94 |
|
|
2021
Q4 | $577K | Buy |
9,923
+50
| +0.5% | +$2.91K | 0.12% | 153 |
|
|
2021
Q3 | $598K | Buy |
9,873
+3,773
| +62% | +$229K | 0.13% | 151 |
|
|
2021
Q2 | $361K | Hold |
6,100
| – | – | 0.08% | 208 |
|
|
2021
Q1 | $332K | Buy |
+6,100
| New | +$332K | 0.08% | 201 |
|